Study Reveals Certain Nasal Bacteria Could Increase COVID-19 Infection Risk

A groundbreaking study conducted by researchers at George Washington University has unveiled a surprising connection between the bacteria residing in our noses and the likelihood of contracting COVID-19. Published in the journal EBioMedicine, the research underscores the critical role that the nasal microbiome might play in modulating an individual’s vulnerability to the virus SARS-CoV-2, which has brought unprecedented challenges to global health.

For years, the scientific community has recognized that SARS-CoV-2 primarily enters the human body through the respiratory tract, with the nose acting as a principal gateway. This research introduces an intriguing twist to that narrative by demonstrating that the bacterial ecosystem within the nasal cavity can modulate levels of key proteins that facilitate the virus’s entry into human cells. According to Cindy Liu, an associate professor of environmental and occupational health at the GW Milken Institute School of Public Health, this discovery opens a new avenue for understanding why certain individuals are more susceptible to severe COVID-19 infection.

The study analyzed nasal swab samples from over 450 participants, including those who later tested positive for COVID-19. Researchers focused on gene expression levels for two crucial proteins: ACE2 and TMPRSS2. ACE2 acts as a receptor that allows the virus to infiltrate nasal epithelial cells, while TMPRSS2 is an enzyme that primes the virus for successful cellular entry by cleaving its spike protein. The findings were arresting: participants who tested positive for COVID-19 showed significantly elevated levels of expression for both proteins compared to non-infected individuals.

Specifically, those with high expression levels of ACE2 and TMPRSS2 were found to be over three times more likely to contract the virus. Even those with moderate expression levels faced double the risk. This correlation not only indicates a direct link between gene expression and infection risk but also points to the dynamic and unstable nature of gene expression in infected individuals. Researchers noted that the sharpest increases in gene expression occurred just days prior to testing positive, suggesting that monitoring these levels could provide critical insights into one’s vulnerability to the virus.

Interestingly, the research also revealed gender disparities in gene expression levels. Women generally exhibited higher levels of ACE2 and TMPRSS2, which aligns with previous observations that indicated higher COVID-19 infection rates among women. Conversely, among men, elevated expression of these proteins was associated with a greater risk of infection, emphasizing the need for gender-specific research and interventions in combating COVID-19.

To investigate the influence of the nasal microbiome on gene expression, the research team examined the diverse assemblage of bacteria residing in nasal passages. The bacterial composition of the nasal microbiome was found to be pivotal in modulating the expression levels of ACE2 and TMPRSS2. Among the various bacterial species identified, three – Staphylococcus aureus, Haemophilus influenzae, and Moraxella catarrhalis/nonliquefaciens – were linked to higher expression levels of the key proteins and consequently increased risk of COVID-19 infection.

On the contrary, a beneficial bacterium named Dolosigranulum pigrum emerged as a potential protective force, linked to decreased levels of ACE2 and TMPRSS2 expression. This finding suggests that specific strains of nasal bacteria could potentially mitigate the risk of viral entry and provide a novel avenue for preventive strategies against respiratory infections.

The study highlights that although harmful bacteria like S. aureus were less prevalent, about 20% of participants carried sufficient quantities that nearly doubled their risk for elevated ACE2 and TMPRSS2 expression. This revelation transforms S. aureus into a significant risk factor within the nasal microbiome, emphasizing the need for preventive strategies that could target bacterial populations to reduce COVID-19 susceptibility.

The implications of this research span beyond understanding infection mechanics; they signify a paradigm shift in how we comprehend the intricate interplay between our microbiomes and overall health. By advocating for further exploration of the nasal microbiome’s role within respiratory health, researchers like Liu encourage the evaluation of novel prevention strategies. Monitoring gene expression of critical proteins such as ACE2 and TMPRSS2 could serve as an early warning system for individuals at heightened risk for COVID-19.

Moreover, there’s ongoing interest in the potential of microbiome manipulation as a therapeutic venture. The team intends to investigate whether interventions designed to modify the nasal microbiome—potentially through nasal sprays or live biotherapeutics—could offer a new layer of protection against viral infections. As the world continues to grapple with the ramifications of COVID-19, innovative research like this provides a beacon of hope for future preventive measures.

In conclusion, the findings from this study signify the need for a holistic approach to understanding health and disease. The interaction between our microbiota and our immune responses can profoundly affect our susceptibility to infections like COVID-19, urging researchers to continuously delve into the nuances of microbiome health. As the world moves forward in the fight against this global pandemic, this research paves the way for new interventions that could bolster our defenses against not just COVID-19, but other respiratory viruses that may emerge in the future.

This new understanding of the nasal microbiome’s involvement in COVID-19 risk sets the stage for further research into how bacteria influence our health. As scientists continue to unravel these complex relationships, we may unlock new strategies for preventing infectious diseases, ultimately leading to better health outcomes for all.

Subject of Research:
Article Title:
News Publication Date:
Web References:
References:
Image Credits:

Keywords: COVID-19, nasal microbiome, gene expression, respiratory infections, ACE2, TMPRSS2, Staphylococcus aureus, Dolosigranulum pigrum, health and medicine, infectious diseases, preventive strategies.

Tags: ACE2 and TMPRSS2 proteinsbacterial influence on virus entryenvironmental health and infectious diseasesgene expression in COVID-19 susceptibilityGeorge Washington University research studymicrobiome and viral infectionsnasal cavity bacterial ecosystemnasal microbiome and COVID-19public health implications of nasal bacteriarespiratory tract and COVID-19SARS-CoV-2 infection risk factorsunderstanding COVID-19 severity